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Background: Recruitment to randomized controlled trials is known to be challenging. It is important to understand
and identify predictors of good or poor accrual to a clinical trial so that appropriate strategies can be put in place
to overcome these problems and facilitate successful trial completion. We have developed a survey tool to
establish the recruitment experience of clinical teams regarding facilitators and barriers to recruitment in a clinical
trial and describe herein the method of developing the questionnaire.
Methods: A literature search was conducted to identify studies that have explored facilitators and barriers to
recruitment, and a list of potential factors affecting recruitment to a clinical trial was generated. These factors were
categorized in terms relating to the (i) trial, (ii) site, (iii) patient, (iv) clinical team, (v) information and consent and (vi)
study team. A list was provided for responders to grade these factors as weak, intermediate or strong facilitators or
barriers to recruitment.
Results: A web-based survey questionnaire was developed. This survey was designed to establish the recruitment
experience of clinical teams with regard to the perceived facilitators and barriers to recruitment, to identify
strategies applied to overcome these problems, and to obtain suggestions for change in the organization of future
trials. The survey tool can be used to assess the recruitment experience of clinical teams in a single/multicenter trial
in any clinical setting or speciality involving adults or children either in an ongoing trial or at trial completion. The
questionnaire is short, easy to administer and to complete, with an estimated completion time of 11 minutes.
Conclusions: We have presented a robust methodology for developing this survey tool that provides an
evidence-based list of potential factors that can affect recruitment to a clinical trial. We recommend that all clinical
trialists should consider using this tool with appropriate trial-specific adaptations to monitor and improve
recruitment performance in an ongoing trial or conduct the survey at trial completion to gather information on
facilitators and barriers to recruitment that can form the basis of interventions and strategies to improve
recruitment to future clinical trials.
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Recruitment to randomized controlled trials is known to
be challenging. However, effective and timely recruit-
ment of appropriate and adequate numbers of research
participants is essential for the successful completion of
a trial and generation of valid results.
Prolonged or inefficient recruitment can have adverse
scientific, economic and ethical consequences [1]. Failure
to achieve the target sample size can lead to a reduction
in the statistical power of a study. An underpowered study
may report clinically important effects to be statistically
non-significant and result in delay or non-implementation
of a clinically effective intervention and delay in identifica-
tion of non-effective interventions. Prolonged recruitment
results in increased time or cost extensions and may result
in premature termination of trials. Studies that terminate
prematurely or fail to reach adequate statistical power
raise ‘ethical’ concerns as trialists have exposed the partici-
pants to an intervention with uncertain benefit and may
still be unable to determine whether the intervention does
more harm than good at trial completion [2].
As under-recruitment is a common cause for trial failure,
it is important to understand and identify the predictors of
good or poor accrual to a clinical trial so that appropriate
strategies can be put in place to overcome these problems
and facilitate successful trial completion.
Several studies have examined recruitment experience
from a number of perspectives. There are reports by
trialists describing their recruitment experience, meth-
ods and strategies [3-10]. There are reports on recruit-
ment and participation of under-represented populations
such as minorities [11,12], adolescents, and young adults
in cancer trials [13]. Studies have tried to assess parents’
or families’ reasons for participation or non-participation
in trials [14-16], and there are several reports of surveys
and interviews with parents or patients investigating the
same [17-24].
Surveys and interviews with clinical teams have inves-
tigated reasons for considering patients unsuitable for a
trial [25], reasons for not entering eligible patients [26],
and difficulties with recruitment to the trial [27,28].
Caldwell et al. [29] conducted focus group discussions
with sixteen pediatricians and five trainees from a
pediatric teaching hospital to evaluate pediatricians’ atti-
tudes toward participation of children in randomized con-
trolled trials and to identify potential barriers to
participation. A number of studies have explored barriers
to trial participation from patients’ and clinicians’ perspec-
tives. Systematic reviews of studies [30-32] reporting bar-
riers to participation in cancer trials have identified various
patient and clinician-related barriers. Fayter et al. [33] con-
ducted a systematic review to investigate the barriers,
modifiers and benefits of participation in randomized
controlled trials of cancer therapies as perceived by healthcare providers or patients and identified system-related or
organizational barriers, trial design-related and health care
provider barriers. Twenty-five studies explored barriers to
participation from the health care perspective, with eight
studies investigating recruitment to specific trials and
seventeen studies investigating attitudes to trials in general.
However, the authors concluded that the studies were of
poor methodological quality and identified threats to
internal validity in terms of potential for selection bias,
non-justification of sample size, lack of reliability and valid-
ity of research instrument, and problems of data collection.
None of the included surveys in this systematic review
provided a comprehensive list of facilitators and barriers to
recruitment.
Cook et al. [34] conducted a survey to explore the
experiences, beliefs and practices of Critical Care Trials
Groups regarding the effectiveness, feasibility and ethics
of strategies to enhance enrollment and views on co-
enrollment of critically ill children and adults into one
or more clinical studies. Fernandez et al. [35] conducted
a trial-specific survey to explore the physicians’ and
parents’ barriers to enrollment in the Children’s
Oncology Group’s study of very low risk Wilm’s tumor.
Spaar et al. [36] conducted a postal survey among
recruiting physicians in a multicenter trial of respiratory
rehabilitation in patients with chronic obstructive pul-
monary disease to identify and weigh barriers to recruit-
ment to the trial. The survey questionnaire comprised
barriers identified in literature that were applicable to the
trial and concerns raised by recruiting physicians during
the recruitment process. Studies [25-28,35] examine
barriers to recruitment in the context of a specific trial or
a specific population, and the survey questionnaires
have been developed as trial or speciality specific
[34]. Spaar et al. investigated some general barriers to
recruitment as well, but not comprehensively, and recruit-
ment facilitators were not identified. We have developed a
survey instrument that can be used to investigate the
experience of clinical teams with regard to both facilitators
and barriers to recruitment to a single/multicenter clinical
trial in any clinical setting or speciality. The survey ques-
tionnaire is evidence-based and has the potential to ex-
plore the generic factors affecting recruitment to a clinical
trial with the scope of adding trial- and speciality-specific
questions, thus providing a reliable tool and systematic
approach to recognition and management of recruitment
problems. To the best of our knowledge, there is no such
existing recruitment survey tool, and we describe herein
the method of developing this survey questionnaire.
Methods
Survey design
The survey has been designed as an online questionnaire
to be completed by study teams involved with
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questionnaire is presented in Figure 1. The survey is
divided into four main sections to collect information
about the site and study role of the responders, the per-
ceived facilitators and barriers to recruitment, strategies
applied to overcome the problems and suggestions for
changes in organization of future trials.
Free-text space is provided for participants to enter in-
formation on their site or center of recruitment, their
role in the study, whether they opened to recruitment,
and their duration and period of involvement if they
were not involved for the whole trial recruitment period.
It is possible to add questions for collecting further in-
formation on the estimated number of eligible
patients, the numbers expected to be randomized,
and the hospital policy on recruitment to the study.
Skip logic can be applied to direct questions selectively
to responders depending on their response to previous
questions so that they may skip questions that do not
apply to them. The second section provides the survey
participants with preformed lists of potential factors
affecting recruitment that could act as facilitators or
barriers to recruitment. 
Defined the aims and scope of the survey and 
population of interest 
Compiled content of the questionnaire: using 
evidence based list of potential factors 
affecting recruitment and providing a mix of 
open and closed questions  
Piloted the survey on a small sample of the 
population of interest: modifications made as 
per feedback received 
Modified version pretested with senior members 
of the project team: further changes made 
Final version of the survey tested and launched  
Figure 1 Process of developing the questionnaire.Writing the questionnaire
A list of potential facilitators and barriers affecting
recruitment to randomized controlled trials was made
from a review of existing literature on the subject. A
literature search on Medline using the search terms ‘re-
cruitment’, ‘enrolment’ combined with the AND connector
to search terms for ‘clinical trials’ and ‘randomised
controlled trials’ identified the major reviews on the
subject that were used to develop the list of factors.
The reviews used to design the survey questionnaire
are briefly described below. The process of selecting and
classifying the factors for inclusion in the survey ques-
tionnaire is presented in Table 1. The Health Technology
Assessment (HTA) report, ‘Factors that limit the quality,
number and progress of randomized controlled trials’ by
Prescott et al. [37] reported patient and clinician barriers
to participation in randomized controlled trials. The
authors of that report conducted a systematic review of
studies that reported problems related to recruitment of
clinicians and patients to clinical trials and identified the
important barriers.
The HTA report ‘Recruitment to randomised trials:
strategies for trial enrolment and participation study:
The STEPS study’ aimed to identify the factors asso-
ciated with good and poor recruitment to multicenter
trials (38). They conducted an epidemiological review
(The STEPS study Part A) of a cohort of trials funded
by the Medical Research Council (MRC) and the
National Health Service Health Technology Assessment
(NHS HTA) program between January 1994 and
December 2002. They tested hypotheses of factors for
association with recruitment success in the cohort of
multicenter randomized controlled trials included in the
review, described patterns of recruitment and reported
trialists’ perceptions of factors associated with good or
poor recruitment. The study also reported the reasons
for delay in recruitment and early and late participant
recruitment problems in the included cohort of trials
based on the trialists’ reports submitted to the funding
bodies. The STEPS study (Part B) reported case studies
of trials that recruited successfully and had particularly
interesting lessons for recruitment. This aim of this part
of the study was to gain role specific and location spe-
cific insights to the four included trials by interviewing
45 individuals in total across the four trials with different
internal perspectives. Four key stages of a trial that may
affect recruitment were identified: 1) foundation work
involving engagement of collaborators, establishing
scientific rigor, funding and financial considerations,
2) recruitment processes, 3) delivery of care and 4)
delivery of research. Common factors in the success
of the included trials were reported based on analysis
of themes identified in the four key stages and from
the responses of the interviewees. Toerien et al. [39]
Table 1 Deriving the factors affecting recruitment from facilitators and from barriers described in literature
Prescott et al. [37]
Barriers to participation in clinical trials: patient and clinician barriers
Barriers Classification Factor derived
Patient barriers
Additional demands of the randomized controlled trials (RCT) on the patient Patient level factors Additional trial investigations
Additional procedures, additional appointments, time pressures, venepuncture,
inpatient hospital stays, discomfort from medical procedures, length of study,
worry about experimentation, uncomfortable procedures, travel and travel
costs, extra costs
Additional travel and extra costs
Duration of trial and follow- up
Patient preference for a particular treatment Patient level factors Patients’/parents’ preference for a particular
treatment
Patients not wanting to change medication, not to take placebo, not to
take experimental medication, not to take any medication, patient request
for a specific intervention, strong patient preference for one treatment option
Patients’/parents’ attitudes towards taking
experimental medicine or placebo
Aversion to treatment choice by random allocation Treatment choice by random allocation
Worry about uncertainty Patient level factors Patients’/parents’ concerns about side
effects of new drug
Efficacy of treatment on offer is unproven, distrust of hospital or medicine,
fear of unknown
Concerns about information and consent Information and
consent related factors
Amount and complexity of trial
information provided
Amount of information provided to research participants, wording of
information, complexity of information provided, different forms of
information presentation: written /verbal/video, limited reading skills and
English not being the primary language, clinicians’ experience, difficulty in
giving information, worry about level of information required and that
information may be frightening, consent procedure barrier to recruitment
Patient level factors Clarity in presentation of trial information
Clinical team factors Experience and training of clinical team
seeking consent
Social and emotional dynamics of
trial discussion
Consent rate
Language or cultural barrier
Difficulty in approaching
patents for consent
Clinician barriers
Time constraints Clinical team factors Clinical workload
Time pressures from usual clinical practice, time demands of recruitment
and follow-up
Staffing and training Clinical team factors Research experience of clinical team
Lack of trained staff, no additional support, lack of research experience
in clinicians, lack of available support staff
Availability of designated research team
Availability of research staff out of hours
Presence of designated research nurse/
practitioner
Rewards and recognition Excluded Information available from the
Chief Investigator
Economic incentives
Impact on doctor patient relationship fear of Adverse effect on doctor-
patient relationship, perceived conflict in their role as clinicians and
researchers
Clinical team factors Clinician attitude to involving
patients in research
Concern for patients
Concern about treatment toxicity, side effects, burden of trial for patients
including travel distance and costs, reluctance to recruit severely ill patients
Problems in complying with the protocol Clinical team factor Clinician preference for a particular
treatment
Trial level factor Study protocol compared
to clinical practice
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Table 1 Deriving the factors affecting recruitment from facilitators and from barriers described in literature (Continued)
Campbell et al. [38]
Hypothesis of factors tested for association with recruitment success
Trials with complex trial design do not recruit as well as simple trials Trial level factor Trial design
Less well-funded trials do not recruit well Trial level factor Funding
Trials without dedicated trial management expertise
do not recruit as well as those with trial management expertise
Trial level factor Trial management
Trial with multidisciplinary input recruit better than those
that do not have this input
Excluded Information available from the
Chief Investigator
Trials with consumer involvement recruit
better than those that do not
Excluded Information available from the
Chief Investigator
Trials that have a successful pilot phase recruit better than
those that do not have a pilot phase
Trial level factor Previous feasibility assessment
Previous pilot trial
Trials that have dedicated paid local coordinators recruit better than
those that do not
Trial management
Cancer trials recruit better than non cancer trials Trial level factor Being a drug/cancer trial
Drug trials recruit better than non-drug trials Being a drug/cancer trial
Trials funded through a response-mode funding have different
recruitment rates to those funded through a commissioned process
Trial level factor Funding
Reasons for delays in recruitment to the included cohort of trials
Problems with central staff, local research staff, internal problems
(for example, staff)
Site level factor Number of trained staff
Clinical team factor Motivation of clinical team
Local clinical arrangements, merging/reorganization of trusts, major
relocation of services, department policies
Site level factor Local clinical arrangements
Funding issues Trial level factor Funding
Delays in ethical clearance Excluded Information available from the
Chief Investigator
Research and Development (R&D) delays,
time delay since grant application
Delays in supply of drug/placebo Excluded Information available from the
Chief Investigator
Adverse publicity about medical research, external problem
(for example, publicity)
Trial level factor Publicity by the trial team
External publicity
Setting up general practitioner (GP) practices took
longer than anticipated
Site level factor Time to open up site
Simultaneous other local research projects, competing research, conflict
with other trials
Site level factor Competing local research projects
Delays due to changes in data legislation, changes in technology Excluded Information available from the
Chief Investigator
Fewer eligible than expected, smaller percentage
agreeing to participate, recruitment targets too ambitious
Trial level factor Lack of pilot/feasibility assessment
Site level factor Recruitment target
Absence of perceived clinical equipoise Trial level factor Clinical equipoise
Issues with procedures/interventions, trial process too demanding Patient level factor Additional trial investigations
Complexity of trial design, trial methodology considered too complex Trial level factor Trial design
Conflicting workload pressures, long waiting lists, additional theatre
time required
Clinical team factor Clinical workload
Language/written English difficulties Patient level factor Language or cultural barrier
Treatment preferences Patient level factor Patients’/parents’ preference
for a particular treatment
Clinical team factor Clinician preference
for particular treatment
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Table 1 Deriving the factors affecting recruitment from facilitators and from barriers described in literature (Continued)
Research not considered as priority Clinical team factor Perceived importance of research
generally in clinical practice
Perceived importance of the particular
research question
No local access to intervention Patient level factor Intervention available only in the trial
Case studies of trials: common factors in the successes of part B trials
Facilitator Classification Factor derived
Important/interesting research question, topic important,
urgent need for research, important question,
timely and managed to roll several questions into one study
Clinical team factor Perceived importance of the particular
research question
Good design/good protocol, pragmatic study Trial level factor Trial design
Study protocol compared
to clinical practice
Clinicians keen to recruit to trial Clinical team factor Motivation of clinical team
Clinician attitude to involving
patients in research
Drugs already tested, so easy to explain to patients Patient level factor Familiarity with experimental treatment
Did not demand extra effort from patients,
Impact on practice running and costs minimized,
minimizing work for health professionals
Patient level factor Additional trial demands
No competing trials for those centers/patients Site level factor Competing local research projects
Drugs not available outside the trial Patient level factor Intervention available only in the trial
Excellent trial management, trial units helpful,
caring, annual meetings for all concerned,
role of trial steering group
Trial level factor Trial management
Good planning and organization by Clinical Trials Support Unit (CTSU),
CTSU responsive, efficient, central organization of
many aspects of research
Good communication between trial team and clinicians,
flexibility of trial teams
Study team factor Communication and coordination among
study team members at site
Good public relations/feedback/updates Trial level factor Trial publicity
Good funding, National Health Service (NHS) funding Trial level factor Funding
Trial run by good team/infrastructure, Principal Investigator (PI) well
respected, PIs worked hard to keep collaborators on board, trial team
communicative, responsive and alert to problems. Communication
within team, between team and collaborating clinicians
Study team factors Motivation of the study team at site
Clinical team factor Research experience of PI and study team
members at site
Good trial team, good research assistants Communication and coordination among
study team members at site
Team worked hard at how to explain the study to patients Communication and coordination
between study team at site and
Clinical Trials Unit (CTU)
Research experience of clinical team
Communication skills of clinical team
Role of research nurse Clinical team factor Presence of designated research nurse/
practitioner
Study included everybody Trial level factor Patient inclusion criteria
Toerien et al. [39]
Study design, number of arms, control: active/placebo Trial level factor Trial design
Single/multicenter Excluded Information will be present
Intervention: drug/surgery/allied/others Trial level factor Being a drug/cancer/surgical/———trial
Funding source Trial level factor Funding
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Table 1 Deriving the factors affecting recruitment from facilitators and from barriers described in literature (Continued)
Caldwell et al. [40]
Recruitment strategies
Novel trial designs Trial level factor Trial design
Recruiter differences Information and
consent related factors
Experience and training of doctors clinical
team seeking consent
Senior doctors and nurses seeking consent
Financial incentives for patients/participants Excluded Monetary incentives not acceptable
for clinical research in United Kingdom
Methods of providing information Information and
consent related factors
Amount and complexity
of information provided
Patient level factor Clarity in presentation of trial information
Consent rate
Treweek et al. [2]
Recruitment strategies
Design changes Trial level factor Trial design
Modification to the consent form or process Patient level factor Consent rate
Modification to the approach made to potential participants Information and
consent related factors
Amount and complexity
of information provided
Clarity in presentation of trial information
Senior doctors and nurses seeking consent
Financial incentives for patients/participants Excluded Monetary incentives not acceptable
for clinical research in United Kingdom
Modification to the training given to recruiters Information and
consent related factors
Experience and training of clinical team
seeking consent
Greater contact between trial coordinator and trial sites Trial level factor Trial management
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mized controlled trials published in six major journals be-
tween July and December 2004 and investigated the
association of these rates with trial characteristics such as
study size, number of arms, single/multicenter, treatment
focus (drug/surgery/allied/others), active/placebo control,
time to assessment and type of funding. The Cochrane
systematic review on strategies to improve recruitment to
randomized controlled trials [2] identified 45 randomized
and quasi-randomized controlled trials of interventions
directed at potential participants or clinicians, which
aimed to improve recruitment of participants to clinical
trials. These interventions were divided into six categories:
design change, modification to the consent form or
process, modification to the approach made to potential
participants, financial incentives for participants, modifica-
tion of training given to recruiters and greater contact be-
tween trial coordinator and trial sites. The systematic
review of strategies for increasing recruitment to rando-
mized controlled trials by Caldwell et al. [40] looked at
the effect of recruitment interventions such as novel trial
designs, recruiter differences, incentives and different
methods of providing trial information on recruitment
success in randomized clinical trials.From the facilitators and barriers reported in the
above studies (37,38) and the potential factors and inter-
ventions tested for association with recruitment success
(2,38-40), a list of potential factors affecting recruitment
was generated by classifying the facilitators and barriers
into various categories. This process is presented in
Table 1. The factors that were generic and expected to
operate commonly at all sites were classified as ‘trial
level factors’. These included factors such as funding for
the trial, trial design, choice of patient inclusion criteria,
type of intervention, previous pilot/feasibility assess-
ment, perception of clinical equipoise, publicity about
the trial, trial management, etcetera The factors which
could operate differentially between sites were classified
as ‘site level factors’ and included factors such as time to
open up site, recruitment target, local clinical arrange-
ments, number and availability of trained staff, compet-
ing research projects and local research culture to list a
few. We excluded factors for which objective informa-
tion is available such as delays in ethical clearance, re-
search and development delays, and problems with
supply of investigational drug/placebo etcetera The
various facilitators and barriers relating to patients’
and clinicians’ participation in clinical trials, as
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tient related and clinical team related factors’. The
factors related to providing information to patients
and seeking consent such as amount and complexity
of trial information, clarity in presentation of trial in-
formation, time and setting of consent seeking and
role and seniority of person seeking consent were
categorized separately as ‘information and consent
related factors’. Lastly, the study team factors such as
motivation and research experience of study team,
communication and coordination between research
teams were presented. Each category formed a separate
question in the survey questionnaire to help the partici-
pants think through the issues arising during recruitment
to the trial.
This section of the survey could be designed to
elicit only barriers, only facilitators, or both barriers
and facilitators to recruitment. In order to decrease
the length of the survey and capture information on
both facilitators and barriers in a common question,
the factors were reworded such that they could apply
both as a facilitator or barrier depending on whether
they boosted or hindered recruitment respectively.
The questions in this section were designed to obtain
graded responses from ‘-3’ to ‘+3’ depending on
whether the factor was perceived to be a strong (−3),
intermediate (−2) or weak barrier (−1), 0 if thought
to be not applicable and weak (+1), intermediate
(+2), or strong facilitator (+3).
Open-type questions were provided to obtain informa-
tion on the various strategies applied to overcome the
problems and for participants to express their reflective
experiences and views on how trials could be organized
differently in the future to improve recruitment.
Pretesting/piloting the questionnaire
The paper version of the questionnaire was sent for
piloting to a small sample of five people. Three out of
the five people (60%) responded. The initial version had
separate lists of facilitators and barriers and participants
were asked to identify the top five in each list. Two
out of the three respondents found the questionnaire
lengthy, difficult to complete and it took them 35 to
40 minutes to do so. Some questions were thought to
be ambiguous and there was a suggestion for use of
computers to enhance the presentation and make it
easier to complete.
After the pilot, the questionnaire was modified. The
length of the questionnaire was reduced by combining the
facilitators and barriers into a single list of factors that
could be graded as either in the same question. Efforts
were made to provide an evidence-based list of factors
affecting recruitment while taking measures to keep the
length of the survey and time of completion withinreasonable limits. Factors for which objective information
was believed to be available from other sources, such as
delays in ethical or research and development approval or
problems with supply of investigational drug/placebo were
excluded from the questionnaire. However, free text space
for additional comments was provided at the end for
responders to note any issues not covered in the survey.
The factors were reworded so that they were simpler
and clearer. An online version was created by using sur-
vey software (www.surveygizmo.com). The questions
were arranged such that they had a logical flow. Each
category of factors was arranged as small separate sec-
tions on a webpage for better presentation and ease of
completion. The participants could easily navigate forward
and backward to revisit a section if they needed to and the
completion time was reduced to 10 to 15 minutes. The
survey instrument (Additional file 1: Figure S1) has been
used to investigate the recruitment experience of clinical
teams in a large multicenter randomized controlled trial
with children in the United Kingdom (MAGNETIC trial).
The response rates are presented here, but the results of
the survey for identified facilitators and barriers, the
strategies applied to overcome these barriers and the sug-
gestions for better organization of trials to improve re-
cruitment, will be published separately. The MAGNETIC
trial was a large multicenter, randomized, double-blind
placebo-controlled trial evaluating the role of nebulized
magnesium in acute severe asthma in children. It
recruited over 500 children over a period of 26 months
from 30 sites across the United Kingdom. The recruit-
ment experience varied across sites and the opportunity to
gather information about this study was believed to be
important. There were three other sites that had opened
to recruitment but did not recruit any patients and four
others where efforts were made to set up the trial but did
not open to recruitment. The survey was sent to all 37
sites as recruitment problems and perspectives of clinical
teams were envisaged to be different at different sites. The
names and contact email addresses of the potential
responders were obtained from the delegation logs. This
included all clinical team members including the Principal
Investigators (PIs), research nurses (RNs),medical practi-
tioners, nursing staff and nurse practitioners, who were
delegated to be involved with recruitment to the trial. The
survey was emailed to 522 contacts at all 37 sites. Since
contact email addresses were expected to change over the
course of the trial, especially for the various clinical staff,
we selectively pursued responses from the Principal
Investigator and at least one research nurse at each site.
Results and discussion
Results
The first section was designed to collect information
about the responder’s study role, site of recruitment and
Kaur et al. Trials 2012, 13:218 Page 9 of 12
http://www.trialsjournal.com/content/13/1/218period and duration of his or her involvement in the trial.
Personal information such as name was not collected;
instead, each survey participant was assigned a unique
identification code for purposes of data collection and
analysis. Information on sites and study role was also used
to examine representation in responses.
The second section provided a comprehensive list of
factors affecting recruitment and the survey participants
were asked to rate each factor from ‘-3’ to ‘+3’ as
described. Each factor could be assigned only one score.
This question was designed in this format to enable us
to deduce the most commonly identified strong barriers
and facilitators and also to enable us to calculate average
scores for each factor. The last section had open-ended
questions to gain information on the interventions
applied and to collate reflective experiences and sugges-
tions of the study team to improve recruitment with
space for additional comments.
The project team sent initial invitations that
described the aims and objectives of the survey, pro-
vided information about the survey, and requested
participation in the survey to the potential partici-
pants. The email provided the link to the online
questionnaire, stated that participation in the survey
was voluntary, and that consent would be assumed by
the person completing the questionnaire. The respon-
ders were reassured that no personal information
such as names would be collected, no site will be
identified in any publication and confidentiality of
data will be maintained.
A total of 169 complete responses were obtained.
We achieved a PI and one research nurse response
per site from 86% and 94% of sites respectively. The
response rates for PIs and RNs (one per site) are
summarized in Table 2.
One hundred percent of the responders completed all
questions ranking the factors affecting recruitment as
facilitators or barriers. Of those responders 108 of 169
(64%) responded to the open question on interventions
or strategies applied to overcome the barriers identified.
Free-text suggestions were obtained from 115 of the 169
(68%) respondents on future reorganization of the trial
to improve recruitment.Table 2 Response rates for survey of facilitators and
barriers to recruitment to the MAGNETIC trial
Sites (n = 37) Principal
investigators n (%)
Research
nurses n (%)
Sites that recruited (n = 30) 28 (93%) 28 (93%)
Sites that opened but did not
recruit (n = 3)
2 (67%) 1 (100%)a
Sites that never opened (n = 4) 2 (50%) 1 (100%)a
Overall response 32 (86%) 30 (94%)
aResearch nurse present at only one site.Discussion
A survey is a systematic method of collecting data from
a population of interest, usually through the use of a
structured and standardized questionnaire [41]. The
methods of conducting survey research can be inter-
views, either face to face or via telephone, or using
postal or electronic questionnaires. The advantages of a
participant-completed questionnaire over an interview
are that it is quicker and cheaper, avoids interviewer bias
and allows respondents to record their responses pri-
vately even to sensitive issues. The disadvantages are
that questions may be misunderstood or not fully
answered by the respondent. There is a greater need to
use closed questions to ensure consistency in the range
of answers and for ease of analysis [42]. E-surveys offer a
number of advantages over paper or telephone survey
techniques in terms of less time and cost requirements,
better accuracy in terms of fewer data transcription
errors, faster creation and delivery, enhanced presenta-
tion and a higher response rates. The potential disadvan-
tages include response bias resulting from unequal
access to internet, issues of authenticity, data security
and confidentiality, and respondent non-response or
procrastination [43].
For these reasons, the recruitment survey question-
naire was developed as an online tool. Care was taken to
avoid errors due to respondent misinterpretation of
questions by phrasing the questions in a simple and
clear manner. A mix of open and closed questions was
provided to obtain accurate responses but also to pro-
vide respondents the freedom to express their views.
Efforts were made to make the survey user-friendly by
arranging the questions in a logical order and reducing
the length of the survey. However, as for any other sur-
vey instrument the generation of useful results depends
on a good response rate from a representative sample of
the population of interest and obtaining true and accur-
ate responses from participants. For the MAGNETIC
trial, the recruitment survey questionnaire achieved a re-
sponse from the Principal Investigator at 86% of the sites
and at least one research nurse response from 94% of
the sites. All the respondents completed the ranking of
factors as facilitators or barriers, and free-text responses
on interventions to overcome barriers and suggestions
for future re-organization were obtained from 64% and
68% of the responders, respectively.
Recruitment to a clinical trial and its conduct is
shaped by various internal and external forces including
the shifting dynamics at sites because of changes in jobs
and roles of staff including periodic turnover of trainee
doctors every few months and change in policies at the
hospital or trust level. Understanding the working of indi-
vidual trials and of trial teams at various sites in a
multicenter trial, with their unique challenges, as well as
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can provide important information that can be used to
inform the design and conduct of future trials [38].
This survey questionnaire could be a very useful tool
to investigate the recruitment experience of clinical
teams and to identify facilitators and barriers to recruit-
ment to a single or multicenter clinical trial in any
clinical setting or speciality involving adults or children.
It provides a common list of questions to participants at
multiple sites and can be used to elicit the facilitators
and barriers to trial participation in general, and can also
be adapted and modified by adding trial specific
questions and highlighting trial- and speciality-specific
recruitment issues. It provides a mix of open and closed
questions and allows for free-text space for participants
to share their experiences and make reflective com-
ments. It is designed to gather data from people with a
range of responsibilities related to recruitment to the
trial. It can be aimed at staff directly involved with re-
cruitment but can also be extended to other staff that
facilitate recruitment or are involved indirectly to gain
an insight into their perspective on issues around re-
cruitment to the trial. The survey can be easily sent to a
large number of participants at the same time. It can be
used to gauge role- and site-specific perceptions of the
research team and can provide a detailed understanding
of the various factors affecting recruitment in addition
to providing information from other monitoring tools
such as screening logs.
This survey tool was designed to be used at the end of
the recruitment phase of a study to identify useful les-
sons for future research and to other trialists. It could be
used however, with some modification, in the pre-trial
phase to identify potential problems or in the early and
middle recruitment phases when observed participation
rate is lower than expected. During a trial, the study
team will often contact under-recruiting sites to obtain
information about problems encountered or will contact
higher than average recruiting sites to identify facilitators.
This tool would provide a more systematic approach to
the collection and consideration of such information,
ensuring that all evidence-based barriers and facilitators
are reviewed by the site in their response, so that appro-
priate strategies can be implemented to overcome the
problems identified. If the survey is to be undertaken
during the recruitment phase to identify modifiable
aspects of the process, factors such as the time taken to
open the site and whether there was a previous feasibility
or pilot study would not be relevant.
Since recruitment performance is usually variable at
different sites, it can be used to investigate the various
site-specific issues. This will not only provide a detailed
understanding of the internal milieu of the trial but also
provides the opportunity for comparison of responsesbetween successful and non-successful sites. Identifica-
tion of facilitators or barriers and strategies applied at
sites with successful recruitment in comparison to less
successful sites may highlight some modifiable differ-
ences, which can form the basis of interventions and
strategies to boost recruitment to an ongoing clinical trial
or provide useful lessons for designing and conducting fu-
ture trials. The survey questionnaire has some potential
limitations. Being a subjective tool, it is prone to re-
sponder misinterpretation, and the authors encourage tri-
alists to pilot the questionnaire with a sample of their trial
team prior to use to ensure consistent understanding of
the listed factors. Though it has been designed to provide
an evidence-based list of generic factors that affect recruit-
ment to clinical trials, the authors would again encourage
trialists to think about other anticipated or observed trial-
specific issues and modify and adapt the questionnaire be-
fore use, taking into consideration the type of trial and the
stage of recruitment. The length of the survey can be
reduced further by excluding factors that are thought to
be not relevant to a particular trial.
Conclusions
Recruitment to clinical trials is a common problem.
Understanding the working of individual trials and iden-
tification of recruitment facilitators and barriers can pro-
vide important information to improve recruitment to
the trial and to help with better design in future trials.
We have developed a recruitment survey tool providing
an evidence-based list of generic factors that can affect
recruitment to a clinical trial. It can be used in any clin-
ical setting or speciality involving adults or children and
can be modified by adding trial-specific issues. Clinical
trialists may identify other trial specific recruitment
issues and make appropriate modifications. Piloting the
survey questionnaire with the trial teams prior to use
is advisable to ensure consistency in the understanding
of terminology.
This survey tool is a potentially useful tool that can
help trialists to approach recruitment problems in a
systematic manner. It has been used successfully to
elicit barriers and facilitators to recruitment in the
MAGNETIC trial but would need further evaluation
in other trials. If proved to be useful, we would recom-
mend that clinical trialists consider using and adapting
this tool to monitor and improve recruitment per-
formance in an ongoing trial or to conduct the survey
at trial completion to gather information on facilita-
tors and barriers to recruitment. This information will
form the basis of interventions and strategies to enhance
recruitment to clinical trials and channelize resources
effectively to counter the problems of under-recruitment
in future clinical research.
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